Alkermes is seeking a highly motivated Associate Director, Health Economics & Outcomes Research (HEOR) to support the development and execution of HEOR strategies within its psychiatry portfolio.
This individual will lead the generation and communication of evidence demonstrating the clinical, economic, and patient-centered value of ARISTADA, Alkermes’ long-acting injectable for people living with schizophrenia. This individual will also support the Head of Psychiatry HEOR on other activities across the psychiatry franchise as needed.
Working closely with cross-functional partners, the successful candidate will support a broad range of HEOR activities, including generation of real-world evidence (RWE), health economic models and assessments, payer value communications, scientific presentations and publications, and other strategic support throughout the product lifecycle.
This position reports to the Head of Psychiatry HEOR and will collaborate extensively with Medical Affairs, Clinical Development, Market Access, Commercial, Legal, Regulatory, external research partners, and thought leaders. This role combines technical expertise, strategic thinking, and cross-functional collaboration.
Alkermes has recently adopted a hybrid working environment to support and meet the needs of employees and this role will operate in a flexible environment with 60% of time in the office and 40% from home. This position is eligible for the hybrid workplace model, requiring work to be completed onsite at our Waltham, MA office at least 3 days per week. This role is not eligible for fully remote work.
Lead the development and execution of HEOR strategies for ARISTADA, including the generation of evidence supporting its clinical, economic, and patient-centered value proposition for payers and physicians
Support the Head of Psychiatry HEOR in the development and execution of HEOR strategies for other Alkermes’ assets across the product lifecycle
Lead and manage HEOR projects, including retrospective observational studies using administrative claims, electronic health records, and other real-world data sources
Support the development of AMCP dossiers, value communication materials, health economic models and assessments, literature reviews, retrospective and prospective observational studies, and other evidence-generation initiatives
Collaborate with cross-functional stakeholders to identify evidence needs and translate strategic objectives into actionable and accountable research plans
Manage external vendors, consultants, and research partners to ensure high-quality, timely study execution while managing budgets appropriately
Support the development of scientific publications, congress presentations, and other scientific communications
Communicate study findings to internal stakeholders and contribute to training and education efforts
Represent Alkermes at scientific meetings, conferences, and professional forums as appropriate
Basic Qualifications:
Doctorate (PhD) or Master’s degree in health economics and outcomes research, pharmacoepidemiology, public health, health services research, health policy, pharmacy, or related field required
5+ years of relevant experience in health economics, outcomes research, RWE generation, epidemiology, or related disciplines within the pharmaceutical, biotechnology, healthcare, academic, or consulting sectors
Preferred Qualifications:
Experience executing projects from concept development through publication with minimal oversight
Experience conducting studies using healthcare databases and other real-world data sources
Familiarity with administrative claims, electronic health records, registries, or other healthcare data assets
Strong project management skills with the ability to manage multiple projects and priorities in a matrix environment
Excellent written and verbal communication skills, including experience contributing to scientific publications and presentations for both technical and non-technical audiences
Experience working effectively across cross-functional teams and with external vendors, research partners, and thought leaders
Ability to work collaboratively, embrace new ideas, contribute to shared learning, and foster a positive work environment
Neuroscience/CNS therapeutic area experience preferred, but not required
#LI-HB1
The annual base salary for this position ranges from $179,000 to $205,000. In addition, this position is eligible for an annual performance pay bonus. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: www.alkermes.com/careers#working-here
Why join Team Alkermes?
Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.
We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized.
Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions.
Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers and broader impacted communities. We remain committed to patient engagement, responsible and sustainable operations, and equitable access to quality treatment.
Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.
See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
